Additional file 32: Table S7. Raw data obtained from cBioPortal for all breast cancer patients separated by MYC amplification status. Redundant patient samples have not been removed.
TNM tumor-node-metastasis, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2, CA 15–3 cancer antigen 15–3, CEA carcinoembryonic angigen, TNBC triple-negativ